Abstract
Stem cell–delivered anti-EGFR nanobodies localize to and inhibit the growth of glioblastoma.
©2012 American Association for Cancer Research.
2012
You do not currently have access to this content.
Skip Nav Destination
Article navigation
1 November 2012
Research Watch|
November 11 2012
EGFR-Targeting Nanobodies Released by Stem Cells Reduce Tumor Growth Available to Purchase
Cancer Discov (2012) 2 (11): 970.
RSS Feeds